MUST READ 

An October 17, 2016 The Age article (Australia) profiled one couple’s journey with early onset Alzheimer’s and their excitement about a new Alzheimer’s clinical trial launching in Austria. According to the article, “They welcomed the news that human trials will begin in Melbourne on Monday for a new drug that has been shown to halt the progression of Alzheimer's disease in mice and to reverse memory loss…The study's lead researcher, Austin Health associate professor Michael Woodward, said the drug, called CT1812, had been found in mice to negate the effects of the toxic protein amyloid beta –  which causes Alzheimer's – at both cellular and behavioural level, and to improve memory.”

An October 15, 2016 ProHealth.com article (via Health Rising) highlighted the increase of funding for Alzheimer’s research at NIH. According to the article, “Alzheimer’s got a huge boost – a 65% increase in funding in one year (from $598 million to $910 million). That surely reflects two things. One, Alzheimer’s has a strong and effective advocacy movement that has been working for years to get to this moment. Two, it’s become clear that Alzheimer’s poses a major threat to our medical system as the population ages.”

An October 15, 2016 The Huffington Post article by Marie Marley highlighted Leeza Gibbons and her caregiving advocacy. According to Marley, “While she does have a star on Hollywood’s Walk of Fame, Leeza is also a powerful star in the world of Alzheimer’s caregiving. Both her mother and grandmother had the disorder, and that’s when she learned first-hand how devastating the disease can be for caregivers. Leeza says that “caring for an Alzheimer’s patient is a situation that can utterly consume the lives and well-being of the people giving care, just as the disorder consumes its victims.”

An October 12, 2016 The Washington Post article profiled how nonprofits are using virtual reality to tackle real-word issues like Alzheimer’s. According to the article, “This virtual reality experience, played out using an Android smartphone, is the work of medical research nonprofit Alzheimer’s Research UK. The organization’s primary mission is to raise money for research into dementia and other memory-related illness, but it also seeks to raise awareness and empathy for a disease that its leaders say the public still poorly understands.”